3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
88
Neoplasm Metastasis
76
Colorectal Neoplasms
75
Neoplasms
73
Leukemia, Myeloid, Acute
64
Breast Neoplasms
57
Prostatic Neoplasms
48
Multiple Myeloma
48
Ovarian Neoplasms
44
Pancreatic Neoplasms
42
Squamous Cell Carcinoma of Head and Neck
39
Melanoma
37
Recurrence
36
Glioblastoma
33
Lung Neoplasms
32
Triple Negative Breast Neoplasms
31
Lymphoma, Non-Hodgkin
31
Myelodysplastic Syndromes
30
Precursor Cell Lymphoblastic Leukemia-Lymphoma
27
Endometrial Neoplasms
27
Advanced Solid Tumors
27
Stomach Neoplasms
25
Carcinoma, Renal Cell
25
Small Cell Lung Carcinoma
24
Sarcoma
23
Brain Neoplasms
23
Carcinoma, Hepatocellular
21
Lymphoma, Large B-Cell, Diffuse
19
Lymphoma, B-Cell
19
Esophageal Neoplasms
19
Interventions
pembrolizumab
1
Histamine H2 Antagonists
1
Famotidine
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Solitary Fibrous Tumors
×
30 days
×
Clear all
NCT06789172
2026-05-22
INVOKE
Epkin
Phase 1
Recruiting
166 enrolled